DA Scheinberg

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 411 citations · Full text

Medicine, Hematology, Pharmacology +10

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 320 citations · Full text

Medicine, Hematology, Pharmacology +10

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid

Linda T. Vahdat, P. Maslak, WH Jr Miller et al. · Blood · 1994 · 303 citations · Full text

Medicine, Hematology, Oncology +15

Specific human cellular immunity to bcr-abl oncogene-derived peptides

Monica Bocchia, Tatyana Korontsvit, Qin Xu et al. · Blood · 1996 · 290 citations

Life Sciences, Immunology, Molecular Biology +9

Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules

Monica Bocchia, PA Wentworth, Scott Southwood et al. · Blood · 1995 · 188 citations · Full text

Life Sciences, Immunology, Oncology +16